E. A. Durak Et Al. , "Stability indicating method development and validation of ranolazine extended release tablets," Acta Pharmaceutica Sciencia , vol.59, no.3, pp.419-434, 2021
Durak, E. A. Et Al. 2021. Stability indicating method development and validation of ranolazine extended release tablets. Acta Pharmaceutica Sciencia , vol.59, no.3 , 419-434.
Durak, E. A., Kurtgöz, İ., MESUT, B., CEVHER, E., & Özsoy, Y., (2021). Stability indicating method development and validation of ranolazine extended release tablets. Acta Pharmaceutica Sciencia , vol.59, no.3, 419-434.
Durak, Yıldız Et Al. "Stability indicating method development and validation of ranolazine extended release tablets," Acta Pharmaceutica Sciencia , vol.59, no.3, 419-434, 2021
Durak, Yıldız Et Al. "Stability indicating method development and validation of ranolazine extended release tablets." Acta Pharmaceutica Sciencia , vol.59, no.3, pp.419-434, 2021
Durak, E. A. Et Al. (2021) . "Stability indicating method development and validation of ranolazine extended release tablets." Acta Pharmaceutica Sciencia , vol.59, no.3, pp.419-434.
@article{article, author={Yıldız ERGİNER Et Al. }, title={Stability indicating method development and validation of ranolazine extended release tablets}, journal={Acta Pharmaceutica Sciencia}, year=2021, pages={419-434} }